{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:41:14Z","timestamp":1790523674387,"version":"4.1.0"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125704","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T17:53:02Z","timestamp":1430329982000},"page":"e0125704","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity"],"prefix":"10.1371","volume":"10","author":[{"given":"Antonella","family":"Cerino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna M.","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Glebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario U.","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(05)00384-7","article-title":"Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention","volume":"34","author":"D Lavanchy","year":"2005","journal-title":"J Clin Virol"},{"key":"ref2","unstructured":"World Health Organization (WHO). Hepatitis B: WHO fact sheet on Hepatitis B providing key facts and information. Fact sheet N\u00b0204. Updated March 2015 Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/<\/ext-link>."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biologicals.2011.09.014","article-title":"Hepatitis B virus in transfusion medicine: still a problem?","volume":"40","author":"JP Allain","year":"2012","journal-title":"Biologicals"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"MH Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jhep.2011.08.026","article-title":"The option of HBIG-free prophylaxis against recurrent HBV","volume":"56","author":"AN Fox","year":"2012","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1053\/jhep.2000.19789","article-title":"Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review","volume":"32","author":"D Shouval","year":"2000","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1128\/JVI.77.16.8882-8892.2003","article-title":"Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions","volume":"77","author":"R Schilling","year":"2003","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"D Samuel","year":"1993","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.510280237","article-title":"Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin","volume":"28","author":"NA Terrault","year":"1998","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus","volume":"10","author":"E Traggiai","year":"2005","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.4049\/jimmunol.147.8.2692","article-title":"Identification of an immunodominant B-cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies","volume":"147","author":"A Cerino","year":"1991","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.4049\/jimmunol.151.12.7005","article-title":"A human monoclonal antibody specific for the N-terminus of hepatitis C virus nucleocapsid protein","volume":"151","author":"A Cerino","year":"1993","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1128\/JVI.68.8.4829-4836.1994","article-title":"Significance of the immune response to a major, conformational B cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody","volume":"68","author":"MU Mondelli","year":"1994","journal-title":"J Virol"},{"key":"ref14","first-page":"451","article-title":"\u201cHepatitis C Protocols\u201d, Methods in Molecular Medicine","author":"MU Mondelli","year":"1998"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jhep.2010.10.019","article-title":"N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus","volume":"55","author":"CM Bremer","year":"2011","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.510240101","article-title":"Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo","volume":"24","author":"E Walter","year":"1996","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1128\/JVI.65.7.3521-3529.1991","article-title":"Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles","volume":"65","author":"K Ueda","year":"1991","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jhep.2000.9632","article-title":"Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and the HBV chronic carrier chimpanzees","volume":"32","author":"R Eren","year":"2000","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.antiviral.2010.04.006","article-title":"Analysis of the epitope and neutralizing capacity of human monoclonal antibodies by hepatitis B vaccine","volume":"87","author":"K Tajiri","year":"2010","journal-title":"Antivir Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.antiviral.2007.01.005","article-title":"Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg)","volume":"75","author":"YW Shin","year":"2007","journal-title":"Antivir Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.antiviral.2008.03.006","article-title":"Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees","volume":"79","author":"SH Kim","year":"2008","journal-title":"Antivir Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/hv.34306","article-title":"Hepatitis B vaccination","volume":"11","author":"L Roman\u00f2","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/lt.23935","article-title":"Frequent incidence of escape mutants after successful hepatitis B vaccine response and stopping of nucleos(t)ide analogues in liver transplant recipients","volume":"20","author":"M Ishigami","year":"2014","journal-title":"Liver Transpl"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.98.6.641","article-title":"Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus","volume":"98","author":"FM Davenport","year":"1953","journal-title":"J Exp Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:49:36Z","timestamp":1748368176000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125704"}},"subtitle":[],"editor":[{"given":"Isabelle A","family":"Chemin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,29]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125704","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,29]]}}}